| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Copyright/Subscription
|
|
|
|
23 |
10 |
p. iv
|
artikel
|
| 2 |
Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia
|
Nguyen, Joehl T.
|
|
|
23 |
10 |
p. 1292-1299
|
artikel
|
| 3 |
Cost-Effectiveness of Ivacaftor Therapy for Treatment of Cystic Fibrosis Patients With the G551D Gating Mutation
|
Wherry, Kael
|
|
|
23 |
10 |
p. 1332-1339
|
artikel
|
| 4 |
Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study
|
Valbert, Frederik
|
|
|
23 |
10 |
p. 1324-1331
|
artikel
|
| 5 |
Costs of Early Invasive Breast Cancer in England Using National Patient-Level Data
|
Sun, Li
|
|
|
23 |
10 |
p. 1316-1323
|
artikel
|
| 6 |
Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China
|
Xie, Shitong
|
|
|
23 |
10 |
p. 1391-1399
|
artikel
|
| 7 |
Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
|
Dakin, Helen A.
|
|
|
23 |
10 |
p. 1340-1348
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
23 |
10 |
p. v
|
artikel
|
| 9 |
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial
|
Reveille, John D.
|
|
|
23 |
10 |
p. 1281-1285
|
artikel
|
| 10 |
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial
|
Husni, M. Elaine
|
|
|
23 |
10 |
p. 1286-1291
|
artikel
|
| 11 |
Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program Decisions: Incremental Cost-Effectiveness Ratio Thresholds and Decision-Modifying Factors
|
Chen, Gengshi
|
|
|
23 |
10 |
p. 1300-1306
|
artikel
|
| 12 |
Health-Related Quality of Life in Neurological Disorders Most Commonly Associated With Zika-Virus Infection: A Systematic Review
|
|
|
|
23 |
10 |
p. 1402
|
artikel
|
| 13 |
How Good Is Machine Learning in Predicting All-Cause 30-Day Hospital Readmission? Evidence From Administrative Data
|
Li, Qing
|
|
|
23 |
10 |
p. 1307-1315
|
artikel
|
| 14 |
Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals
|
Pennington, Becky M.
|
|
|
23 |
10 |
p. 1349-1357
|
artikel
|
| 15 |
Is Multicriteria Decision Analysis a Resource Allocation Framework?
|
Dionne, François
|
|
|
23 |
10 |
p. 1400-1401
|
artikel
|
| 16 |
Patient Preferences in Surveillance: Findings From a Discrete Choice Experiment in the “My Follow-Up” Study
|
McFerran, Ethna
|
|
|
23 |
10 |
p. 1373-1383
|
artikel
|
| 17 |
Table of Contents
|
|
|
|
23 |
10 |
p. i-iii
|
artikel
|
| 18 |
Trade-Offs in Quality-of-Life Assessment Between the Modified Rankin Scale and Neuro-QoL Measures
|
Askew, Robert L.
|
|
|
23 |
10 |
p. 1366-1372
|
artikel
|
| 19 |
Use of Real-World Evidence to Support FDA Approval of Oncology Drugs
|
Feinberg, Bruce A.
|
|
|
23 |
10 |
p. 1358-1365
|
artikel
|
| 20 |
Willingness to Pay for Health Improvements Using Stated Preferences: Prevention Versus Treatment
|
Wolff, Ellen
|
|
|
23 |
10 |
p. 1384-1390
|
artikel
|
Tijdschrift beschrijving